Upgrade to see which companies are likely to bid on this tender, based on historical procurement data.
LoginAI requirements analysis not yet available for this tender.
Requirements will be generated automatically when tender documents are processed.
5 documents available with AI summaries
This document is a supplier's declaration regarding grounds for exclusion, specifically for the drug Levobupivacaine (CPO not present, PU-92/2026), to be effective from February 1, 2025.
This document contains the tender conditions for the procurement of the medication Levobupivacain by VšĮ Jonavos ligoninė, specifying the object, qualification requirements, proposal submission process, and contract terms.
This document is a supplier's declaration confirming the absence of conditions set out in Council Regulation (EU) 2022/576, and requires current data as of the submission date, with an authorization if signed by an employee other than the CEO.
This document contains a tender notice for the procurement of the drug Levobupivacaine by VšĮ Jonavos ligoninė in Lithuania.
This document contains the complete tender structure for an open procedure with the lowest price evaluation criteria for VAISTAS LEVOBUPIVACAIN (CPO NĖRA, PU92/2026).
Sign up to view document summaries and analysis
This tender for Levobupivacaine is generally well-structured with clear documentation and adherence to EU procurement principles. However, the lack of disclosed financial value and specific evaluation criteria slightly impacts its completeness and fairness.
The tender follows the open procedure (2014/24/ES) and utilizes the correct CPV code for pharmaceutical products. The presence of mandatory exclusion grounds and eligibility requirements indicates a focus on regulatory compliance. The short submission deadline is a minor concern but within typical parameters for low-value procurements.
The tender title and description are clear, and the provided documents offer summaries of their content. The AI-extracted requirements list key areas that bidders need to address. However, the absence of specified evaluation criteria leaves some ambiguity regarding how bids will be assessed.
Most basic information is present, including the organization, reference number, and contract duration. However, the estimated value is not disclosed, which is a significant omission for potential bidders. The availability of 5 tender documents is positive.
The tender is conducted via e-procurement, promoting transparency. The requirements listed (exclusion, eligibility, technical, financial) are standard and objective. The lack of disclosed value is a slight detractor from full fairness, but the overall process appears equitable.
The tender is marked as 'E-Procurement', suggesting an electronic submission process. The contract duration of 12 months is clearly specified. However, the 'No e-submission' flag in the checks suggests a potential contradiction or missing detail regarding the submission mechanism.
Key fields such as title, reference, organization, and contract duration are populated. There are no reported disputes or suspensions. The dates provided are logical, with the opening date following the submission deadline.
The tender is EU funded, which often implies adherence to certain standards. However, there are no explicit mentions of green procurement, social aspects, or innovation within the provided information, leading to a moderate score in this category.
Sign up to view complete requirements and analysis
No credit card required • Setup in 2 minutes
Our procurement experts prepare everything. Proven to work — you review, approve, and submit.
Hello! I'm your AI assistant for this tender. I can help you understand requirements, deadlines, eligibility criteria, and provide strategic insights.
No credit card required